Development of Folic Acid-Conjugated Iron Oxide Nanoparticles Loaded with Doxorubicin via Arc Discharge: A Novel Approach for Synergistic Photothermal-Chemotherapy of Cancer Using Bacterial Cellulose-Polyvinyl Alcohol Hydrogel

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-15

This study developed folic acid-conjugated iron oxide nanoparticles loaded with doxorubicin within a bacterial cellulose-polyvinyl alcohol hydrogel for synergistic photothermal and chemotherapy, showing enhanced efficacy in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-15 · read from full text

The paper studied a multifunctional therapeutic hydrogel combining folic acid–conjugated, arc-discharge–synthesized iron oxide nanoparticles loaded with doxorubicin and embedded in a bacterial cellulose/polyvinyl alcohol matrix, aiming for chemo–photothermal synergy. Using XRD, SEM, UV–Vis spectroscopy, magnetization, and hydrogel property analyses (swelling, rheology), the authors report that arc discharge produced crystalline, high-purity iron oxide nanoparticles with a narrow size distribution, that folic acid enabled tumor-targeted delivery, and that doxorubicin loading occurred via electrostatic and π–π interactions with sustained release from the hydrogel. In vitro experiments showed enhanced cancer cell killing under near-infrared irradiation, with combined photothermal/chemotherapy producing greater viability reduction than single-modality treatment. The paper’s main caveat is that results are presented at the in vitro level without an explicit in vivo efficacy or safety evaluation. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The design of multifunctional nanomaterials that combine chemotherapy with photothermal therapy (PTT) has emerged as a promising strategy to overcome the limitations of conventional cancer treatments. Here, we report the fabrication of a novel therapeutic hydrogel system composed of Folic Acid-functionalized iron oxide nanoparticles (IO NPs) synthesized via an arc-discharge method, loaded with doxorubicin (DOX), and embedded within a bacterial cellulose/polyvinyl alcohol (BC/PVA) matrix. The arc-discharge technique produced crystalline FeNPs with high purity and narrow size distribution. Folic acid conjugation enabled tumor-targeted delivery, while DOX was efficiently incorporated via electrostatic and π–π stacking interactions. Embedding in the BC/PVA hydrogel facilitated sustained drug release and improved biocompatibility. Structural and functional characterization was conducted using X-ray diffraction (XRD), scanning electron microscopy (SEM), UV–Vis spectroscopy, magnetization studies, swelling and rheological analysis, and photothermal heating experiments. In vitro cancer cell studies demonstrated enhanced therapeutic efficacy of the hydrogel system under near-infrared (NIR) irradiation, where synergistic chemo-photothermal effects resulted in significant reduction in cell viability compared to single-mode treatments. This study highlights a multifunctional nanoplatform that integrates targeted delivery, controlled release, and dual therapeutic modalities for effective cancer treatment.
Full text 1,604 characters · extracted from oa-doi-fallback · click to expand
Abstract The design of multifunctional nanomaterials that combine chemotherapy with photothermal therapy (PTT) has emerged as a promising strategy to overcome the limitations of conventional cancer treatments. Here, we report the fabrication of a novel therapeutic hydrogel system composed of Folic Acid-functionalized iron oxide nanoparticles (IO NPs) synthesized via an arc-discharge method, loaded with doxorubicin (DOX), and embedded within a bacterial cellulose/polyvinyl alcohol (BC/PVA) matrix. The arc-discharge technique produced crystalline FeNPs with high purity and narrow size distribution. Folic acid conjugation enabled tumor-targeted delivery, while DOX was efficiently incorporated via electrostatic and π–π stacking interactions. Embedding in the BC/PVA hydrogel facilitated sustained drug release and improved biocompatibility. Structural and functional characterization was conducted using X-ray diffraction (XRD), scanning electron microscopy (SEM), UV–Vis spectroscopy, magnetization studies, swelling and rheological analysis, and photothermal heating experiments. In vitro cancer cell studies demonstrated enhanced therapeutic efficacy of the hydrogel system under near-infrared (NIR) irradiation, where synergistic chemo-photothermal effects resulted in significant reduction in cell viability compared to single-mode treatments. This study highlights a multifunctional nanoplatform that integrates targeted delivery, controlled release, and dual therapeutic modalities for effective cancer treatment. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00